Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content

Table 1 Human mediotemporal gyrus samples used in this study

From: Sorting nexin-4 regulates β-amyloid production by modulating β-site-activating cleavage enzyme-1

Diagnosis

Sex

Age (years)

Braak stage

Amyloid

PMD (h:minutes)

pH

Weight (g)

Alzheimer’s disease

M

85

5

C

07:10

6.13

1020

Alzheimer’s disease

M

65

6

C

08:50

6.88

1057

Alzheimer’s disease

M

65

5

C

05:50

6.36

1355

Alzheimer’s disease

M

65

5

C

07:20

6.47

1173

Alzheimer’s disease

M

87

5

C

06:10

6.14

1047

Alzheimer’s disease

M

67

5

C

04:10

6.40

1252

Alzheimer’s disease

M

70

6

C

04:50

6.95

1040

Alzheimer’s disease

M

82

5

C

05:15

6.34

1182

Nondemented control

M

73

0

O

24:45

?

1267

Nondemented control

M

71

1

O

07:40

6.20

1150

Nondemented control

M

87

1

A

10:20

6.32

1256

Nondemented control

M

80

0

O

07:15

5.80

1331

Nondemented control

M

84

1

A

05:35

6.98

1337

Nondemented control

M

82

1

O

05:10

6.75

1087

Nondemented control

M

78

1

O

<17:40

6.52

1125

  1. Mediotemporal gyri from eight patients with AD and seven age- and sex-matched controls were provided by the Netherlands Brain Bank. Braak stages based on neurofibrillary tangles were 5 or 6 in subjects with Alzheimer’s disease (AD) and 0 or 1 in the controls [24]. Braak stages based on amyloid plaques were C in AD cases and 0 or A in the controls [24]. Tissue preparation time from death is displayed as postmortem delay (PMD)
Back to article page

Alzheimer's Research & Therapy

ISSN: 1758-9193